Friday, May 3, 2013
At the 2nd Annual Whitehead Symposium, Whitehead Institute's groundbreaking research comes to New York City. Attendees at this half-day, morning event will hear from three of Whitehead Institute's world-renowned scientists on their efforts to decipher such devastating human maladies as cancer, autism and diabetes.
Breakfast & registration
Connections: Unexpected Paths to Conquering Human Disease
with Whitehead Institute Member Hazel Sive, PhD
Mimicking Methuselah: Developing a Drug to Extend Lifespan
with Whitehead Institute Member David Sabatini, MD, PhD
Carcinoma Crackdown: Targeting Breast Cancer Progression and Drug Resistance
with Whitehead Institute Founding Member Robert Weinberg, PhD
Coffee + conversation
Please use this form to register for the Whitehead Symposium. If you have any questions or issues, please contact Lauren Gilbert at (617) 258-5489 or firstname.lastname@example.org.
Founding Member of Whitehead Institute Robert Weinberg, PhD, has long been at the forefront of cancer research and is widely known for his landmark discovery of the first human oncogene, a gene that causes normal cells to form tumors. Today, much of Bob's work is propelled by his own recent discovery that certain tumor cells undergo a change that enables them to leave the primary tumor and form new tumors in remote locations of the body.
Whitehead Institute Member David Sabatini, MD, PhD, studies the mechanisms that regulate cell growth, the process whereby cells accumulate mass and increase in size. David has been studying a particular growth regulator known as the mechanistic Target of Rapamycin (mTOR) since he first identified the pathway as a graduate student. Since then, David has shown that the mTOR pathway not only plays a critical role in the progression of diabetes and cancer, but also may be exploited to increase human lifespan.
Whitehead Institute Member Hazel Sive, PhD, studies embryonic development and her research on the genetic basis of proper structural formation of the brain has contributed to our understanding of birth defects and numerous developmental disorders. She is currently using the uniquely transparent zebrafish—which enables direct observation of the developing brain—as a tool for identifying genes that may be associated with autism and other mental health disorders.
The 2013 Whitehead Symposium will be held on May 3rd at the New York Yacht Club in Manhattan. The Club is located at 37 West 44th Street (between 5th and 6th Avenues), New York, New York 10036. Business casual dress is required.
If you have any questions about the Whitehead Symposium, please contact Lauren Gilbert at (617) 258-5489 or email@example.com. For more information about our scientists and research program, we encourage you to visit Whitehead Institute's homepage.
Frequently Asked Questions
What is the Whitehead Symposium?
Whitehead Institute hosts various events throughout the year, providing opportunities for supporters, friends and members of the Whitehead community to learn about our latest research and interact with our scientists. The Whitehead Symposium, held each May in New York City, is one of our signature annual events, providing attendees with a front-row seat to the latest breakthroughs in biomedicine.
What is Whitehead Institute?
Whitehead Institute is a world-renowned non-profit research institution dedicated to improving human health through basic research. By fostering a deeply collaborative culture and enabling the pursuit of wildly creative research, Whitehead provides the ideal environment for paradigm shifting scientific achievements. For over twenty-five years, Whitehead researchers have delivered breakthroughs that have transformed our understanding of biology and accelerated the treatment of such diseases as cancer, Alzheimer's and diabetes. Visit the Whitehead Institute homepage.
© Whitehead Institute, 2013. Nine Cambridge Center, Cambridge, MA 02142.